EDITORIAL
Published on 23 Oct 2023
Editorial: Biomarkers and immunotherapy of hepatic-biliary-pancreatic cancers
doi 10.3389/fonc.2023.1301416
- 652 views
- Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Research Topics
- Biomarkers and Immunotherapy of Hepatic-Biliary-Pancreatic Cancers
Biomarkers and Immunotherapy of Hepatic-Biliary-Pancreatic Cancers
81k
Total Downloads
195k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 28 Jul 2023
Functional reprogramming of peripheral blood monocytes by soluble mediators in patients with pancreatic cancer and intraductal papillary mucinous neoplasms
doi 10.3389/fimmu.2023.1116034
- 1,522 views
- 1 citation
SYSTEMATIC REVIEW
Published on 17 Apr 2023
Prognostic value of programmed cell death ligand 1 expression in patients with intrahepatic cholangiocarcinoma: a meta-analysis
doi 10.3389/fimmu.2023.1119168
- 1,139 views
- 4 citations
ORIGINAL RESEARCH
Published on 06 Apr 2023
Transmembrane protein 88 suppresses hepatocellular carcinoma progression and serves as a novel prognostic factor
doi 10.3389/fonc.2023.1148498
- 1,377 views
- 1 citation
CLINICAL TRIAL
Published on 28 Mar 2023
Multicenter, single-arm, phase II study (CAP) of radiotherapy plus liposomal irinotecan followed by camrelizumab and anti-angiogenic treatment in advanced solid tumors
doi 10.3389/fimmu.2023.1133689
- 1,960 views
- 3 citations
ORIGINAL RESEARCH
Published on 28 Mar 2023
Chromosome 11q13 amplification correlates with poor response and prognosis to PD-1 blockade in unresectable hepatocellular carcinoma
doi 10.3389/fimmu.2023.1116057
- 2,087 views
- 2 citations
ORIGINAL RESEARCH
Published on 27 Mar 2023
Molecular subtype identification and signature construction based on Golgi apparatus-related genes for better prediction prognosis and immunotherapy response in hepatocellular carcinoma
doi 10.3389/fimmu.2023.1113455
- 2,225 views
- 5 citations
ORIGINAL RESEARCH
Published on 24 Mar 2023
Immune-related adverse events correlate with the efficacy of PD-1 inhibitors combination therapy in advanced cholangiocarcinoma patients: A retrospective cohort study
doi 10.3389/fimmu.2023.1141148
- 1,105 views
- 4 citations
CORRECTION
Published on 23 Mar 2023
Corrigendum: Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies
doi 10.3389/fimmu.2023.1177713
- 649 views
CASE REPORT
Published on 20 Mar 2023
Case report: Preliminary response to tislelizumab plus S-1 in patients with metastatic gallbladder carcinoma: A report of five cases and a literature review
doi 10.3389/fimmu.2023.1144371
- 2,492 views
- 3 citations
REVIEW
Published on 17 Mar 2023
SMC4, a novel tumor prognostic marker and potential tumor therapeutic target
doi 10.3389/fonc.2023.1117642
- 2,812 views
- 3 citations
ORIGINAL RESEARCH
Published on 02 Mar 2023
A novel liver zonation phenotype-associated molecular classification of hepatocellular carcinoma
doi 10.3389/fimmu.2023.1140201
- 3,849 views
- 1 citation
Published in
Frontiers in Oncology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Immunology
- 5.7 impact factor
- 9.8 citescore
Impact
- 195kTopic views
- 112kArticle views
- 81kArticle downloads